Structures of motilin and ghrelin
Motilin was initially isolated from a side fraction produced during the purification of secretin by Brown et al. in 1971 (Brown, et al. 1971 , and the complete amino acid sequence of motilin was determined in 1973 (Brown, et al. 1973) . Mature motilin is a 22-amino-acid polypeptide with a molecular weight of 2698, and motilin has been isolated from humans (Strausberg, et al. 2002) , pigs (Khan, et al. 1990 ) (Bond, et al. 1988 ), dogs (Ohshiro, et al. 2008) , cats (Xu, et al. 2003) , guinea pigs (Xu, et al. 2001) , rabbits (Banfield, et al. 1992) , and chickens (De Clercq, et al. 1996) . We recently identified and cloned suncus motilin as a useful small animal model, and the mature region of suncus motilin is highly conserved between these species ). The precursor of motilin consists of 133 amino acids and includes a 25-amino-acid signal peptide followed by a 22-amino-acid motilin sequence and a motilin-associated peptide (MAP) (Banfield et al. 1992) . The amino acid sequence of MAP is also conserved between species, but the functional and physiological roles of MAP have not been elucidated. Ghrelin was identified from rat and human stomach extracts by Kojima et al. in 1999 using a "reverse pharmacology" strategy (Kojima, et al. 1999) . In mice, rats and humans, ghrelin is a 28-amino-acids polypeptide and, interestingly, ghrelin has an acyl modification at the third serine by n-octanoate, one of the medium chain fatty acids (Kojima et al. 1999 ). Ghrelin exists as two different molecular forms, acyl ghrelin (modified form) and des-acyl ghrelin (unmodified form), in both gastric ghrelin-producing cells and circulation (Ariyasu, et al. 2001; Fujimiya, et al.) . Ghrelin has been identified in many species, including mammlas, avians (Kaiya, et al. 2002; Wada, et al. 2003) , amphibians (Kaiya, et al. 2001; Kaiya, et al. 2006) , reptilian (Kaiya, et al. 2004) , and fish Miura, et al. 2009 ), and the sequence of first seven amino acids of the N-terminal region of ghrelin are highly conserved between species (Kojima, et al. 2008 ). In addition, it has been reported that the first four or five amino acids are sufficient for calcium mobilization in vitro (Bednarek, et al. 2000) .
Distributions of motilin-and ghrelin-producing cells
The distribution of motilin-producing cells in the gastrointestinal tract has been studied by using immunohistochemistry and in situ hybridization techniques. Since motilin is genetically knockdown in rats and mice, the distribution and morphology of motilinproducing cells were investigated using rabbits (Satoh et al. 1995) , monkeys, and humans (Helmstaedter, et al. 1979) . In rabbits, motilin-immunopositive cells were found in the epithelia of the crypts and villi throughout the gastrointestinal tract from the gastric antrum to the distal colon, but no immunostaining was observed in the gastric body (Satoh et al. 1995) , and motilin-producing cells were localized abundantly in the upper small intestine. Cell densities (cells/mm 2 , mean ± SE) were 0.41 ± 0.16 in the gastric antrum, 8.2 ± 0.8 in the duodenum, 1.9 ±0.5 in the jejunum, 0.62 ± 0.14 in the ileum, 0.19 ± 0.05 in the cecum, 0.13 ± 0.03 in the proximal colon, and 0.39 ± 0.18 in the distal colon (Satoh et al. 1995) . Immunoelectron microscopic observations revealed that the motilin-producing cell is characterized by relatively small (180 nm in man; 200 nm in the dog) solid granules with a homogeneous core and closely applied membrane, round in man and round to irregularlywww.intechopen.com
The Gut Peptide Hormone Family, Motilin and Ghrelin 5 shaped in the dog. Recently, we succeeded in identification of suncus motilin cDNA and amino acid sequence ), and immunohistochemical analysis was performed in all regions of the gastrointestinal tract and also in situ hybridization analysis was performed to detect motilin mRNA-expressing cells. Motilin-immunopositive and expressing cells in suncus were observed in the mucosal layer but not in the myenteric plexus and were abundantly distributed in the upper intestine. However, the density of motilin mRNA-expressing cells was slightly higher than that of motilin-immunopositive cells, suggesting low accumulation of motilin in the cytoplasm. In addition, motilinproducing cells in suncus were closed-and opened-type cells as previously reported in other mammals. Gastric ghrelin cells had been classified as X/A-like cells by their round, compact, electrondense secretory granules that distinguish them electron-microscopically from other previously characterized gastric endocrine cell types before the discovery of ghrelin (Dornonville de la Cour et al. 2001 ) (Date, et al. 2000 . The distribution of ghrelin-producing cells in the gastrointestinal tract has been studied in many species. Ghrelin-producing cells were most dense in the gastric body and were found in the mucosal layer but not in the myenteric plexus in all of the examined regions of rats (Sakata et al. 2002) . In the stomach, most of the ghrelin cells were observed in the glandular base to body of the fundic gland, and a few ghrelin cells were observed in the glandular neck. In rodents, in addition to the stomach, ghrelin-producing cells were observed in all regions of the gastrointestinal tract, including the duodenum, ileum, cecum and colon (Sakata et al. 2002) . In the duodenum, ileum, cecum and colon, ghrelin cells were scattered in the epithelia of crypts and villi, and the densities of ghrelin cells were dramatically decreased toward the lower gastrointestinal tract. In the stomach, ghrelin-producing cells were observed as small and round-shaped cells (called closed-type cells). On the other hand, in the duodenum, ileum, cecum and colon, ghrelin cells were found as two different types of endocrine cells, closed-type cells with triangular or elongated shapes and opened-type cells with their apical cytoplasmic process in contact with the lumen. In suncus, ghrelin-producing cells were abundant in the stomach and most of the ghrelin cells were closed-type cells with relatively rich cytoplasm and scattered in the glandular body and base of the gastric mucosa (Ishida, et al. 2009 ). Using electron microscopic observation, immunogold labeling for ghrelin has been shown to be localized on round and electron-dense granules in gastric mucosal cells. The diameters of granules containing ghrelin in mice (277.7 ± 11.1 nm) and rats (268.8 ± 13.0 nm) were similar; however, those in hamsters (200.8 ± 8.8 nm) were significantly smaller than those in mice or rats. Rindi et al. demonstrated that mouse and canine ghrelin-immunoreactive cells closely resembled those of the human stomach, though it has been shown that dog ghrelin cells have obviously larger granules (273 ± 49 nm) than those of rats (183 ± 37 nm) and humans (147 ± 30 nm). Co-localization of motilin and ghrelin was examined in the human biopsy and tissues from pig by immunohistochemistry and in situ hybridization in a study by Wierup et al. (Wierup, et al. 2007) . They showed that ghrelin and motilin are coproduced in the same cells in the duodenum and jejunum of humans and pigs and that ghrelin and motilin are stored in all secretory granules of such cells in humans, suggesting that motilin and ghrelin are cosecreted by the same stimulus (Wierup et al. 2007 ). As mentioned above, suncus is a small laboratory animal that produces both motilin and ghrelin, and further studies are therefore needed to examine the co-localization of motilin and ghrelin in the duodenum and lower intestine of suncus.
Distributions of motilin and ghrelin receptors
The receptor for motilin was identified from the human gastrointestinal tract by Feighner et al. in 1999 (Feighner, et al. 1999 and it is now called GPR38 or motilin receptor. Growth hormone secretagogue receptor (GHS-R) was initially identified from the pituitary gland and brain in 1996 (Howard, et al. 1996) , and GHS-R had been known as the orphan receptor until ghrelin was discovered. In the process of exploring the natural ligand for the GHS-R using reverse pharmacology, ghrelin was discovered as an endogenous ligand for GHS-R. Both motilin and ghrelin receptors belong to the seven transmembrane G protein-coupled receptor family (McKee, et al. 1997) , and these receptors showed high sequence homology of 52 % to each other in humans (Takeshita, et al. 2006) . The tissue distribution of motilin and ghrelin receptors has been mainly examined using binding assays or mRNA analysis with RT-PCR. Motilin binding sites were found on smooth muscle layers of the gastric antrum, duodenum and colon, but no positive binding reaction was detected in the smooth muscle layer of the cecum (Sakai, et al. 1994b ). Specific binding sites were particularly abundant in the circular muscle layers, with low concentrations in longitudinal muscle layers of the gastric antrum, duodenum and colon, and no motilin binding sites were found in the mucosa of the gastrointestinal tract and pancreas (Sakai et al. 1994b ). mRNA analysis showed that motilin receptor was expressed in the gastrointestinal tract in humans (Takeshita et al. 2006; Ter Beek, et al. 2008 ), dogs (Ohshiro et al. 2008 , guinea pigs (Xu, et al. 2005 ) and chickens (Yamamoto, et al. 2008 ). It has also been shown that motilin receptor immunoreactivity was present in muscle cells and the myenteric plexus, but not in mucosal or submucosal cells in humans (Takeshita et al. 2006) . In dogs, motilin receptor immunoreactivity was observed among muscle fibers on both the longitudinal and circular muscle layers (Ohshiro et al. 2008 ). In the guinea pig stomach, motilin receptor immunoreactivity was also found in the myenteric plexus, consistent with findings in humans and dogs (Xu et al. 2005) . In addition to gastrointestinal tract, Depoortere et al. reported that specific binding sites for the motilin receptor were observed in the hippocampus, thalamus, hypothalamus and amygdaloid body in the central nervous system (Depoortere, et al. 1997 ). On the other hand, distribution of the ghrelin receptor (GHS-R) has been studied in detail in several species, and it has been shown that the ghrelin receptor is expressed widely in the body from the central nervous system to peripheral organs. In rodents, expression of ghrelin receptor mRNA was observed in the various of regions of the brain, with high expression levels in Arcuate nucleus (Arc), Ventromedial nucleus, Ventral tegmental area (VTA), hippocampus and the nucleus of solitary tract (NTS) (Zigman, et al. 2006 ) (Mondal, et al. 2005 ) (Guan, et al. 1997 ). In addition, high expression levels of GHS-R were found in the pituitary gland (Kamegai, et al. 2001 ) (Gnanapavan, et al. 2002) and pancreas (Kageyama, et al. 2005 ) (Volante, et al. 2002) . In the gastrointestinal tract, ghrelin receptor mRNA expression was also found throughout the stomach and intestines, and expression of the ghrelin receptor was detected in the muscle layer but not in the mucosal layer in the stomach (Date et al. 2000) . Moreover, it has been reported that ghrelin receptor immunoreactivity was found within neuronal cell bodies and fibers in rats (Dass, et al. 2003) and that ghrelin receptor mRNA transcripts were found in longitudinal muscle/myenteric plexus preparations and in cultured myenteric neurons of the guinea pig (Xu et al. 2005) 
Roles of motilin and ghrelin in gastric motility
7 gastrointestinal motility in the interdigestive state. It has been reported that these coordinated contractions consist of three phases, phase I (period of motor quiescence), phase II (period of preceding irregular contractions) and phase III (period of clustered potent contractions). It has been shown that plasma concentration of motilin changed in a cyclic fashion and that it has rhythmus occurring every 90-100 min. In fact, administration of motilin has been shown to induce phase III-like contraction via the cholinergic pathway, and endogenous motilin is thought to be physiologically important for phase III contraction (Vantrappen, et al. 1979 ) (Itoh, et al. 1978 ). Since the ghrelin receptor is expressed in the gastrointestinal tract, the effect of ghrelin on gastric motility has also been examined. In rats, ghrelin exerts stimulatory effects on motility of the antrum and duodenum in both fed and fasted states (Fujimiya, et al. 2008) , and Taniguchi et al. reported that ghrelin infusion significantly increased motility index of phase III-like contractions at the antrum and jejunum in a dose dependent manner (Taniguchi, et al. 2008) . As well as the rat stomach, phase III-like contractions in mice were observed in the interdigestive state, and no spontaneous phase III-like contractions were found in vagotomized mice, suggesting that ghrelin-induced gastric phase III-like contractions are mediated via vagal cholinergic pathways in mice (Zheng, et al. 2009 ). In humans, administration of ghrelin induced a premature gastric phase III of the MMC, which was not mediated through release of motilin (Tack, et al. 2006) . As a new model to study gastric motility, we established an in vitro and in vivo functional assay system using suncus. Administration of suncus motilin showed almost the same contractile effect as that of human motilin in vitro ). During the fasted state, the suncus stomach and duodenum showed clear migrating phase III contractions (intervals of 80-150 min) as found in humans and dogs, and motilin injection also increased the gastric motility index in a dose-dependent manner (Sakahara, et al. 2010) . Moreover, pretreatment with atropine completely abolished the motilin-induced gastric phase III contractions (Sakahara et al. 2010) . Since suncus has almost the same GI motility and motilin response as those found in humans and dogs, suncus would be a suitable model to analyze the interaction of motilin and ghrelin in gastric motility.
Plasma profiles and secretion of motilin and ghrelin in the gastrointestinal tract
Motilin is mainly produced in the duodenum and secreted into the blood stream. During the interdigestive state, it was found that plasma motilin concentration increased in complete accordance with the cyclical interdigestive contractions of the stomach in dogs (Itoh et al. 1978) . Furthermore, plasma motilin concentration was lowered by ingestion of food, and it remained low as long as the gastric motor activity was in the digestive pattern (Itoh et al. 1978) . It has been demonstrated that plasma motilin is released at about 100-min intervals in the interdigestive state in humans (Vantrappen et al. 1979 ) and dogs (Itoh et al. 1978 ). Zietlow et al. also reported that the peak of plasma motilin levels was always observed in the period of gastric phase III contractions (Zietlow, et al. 2010) . Inverse correlations were found between plasma motilin concentration and glucose and between motilin concentration and insulin, suggesting that glucose and/or insulin are important in suppressing motilin secretion during feeding (Funakoshi, et al. 1985) . Dopamine infusion caused a significant decline of plasma motilin levels, and dopamine antagonism with domperidone caused a significant elevation of motilin (Funakoshi, et al. 1983 ). Atropine suppressed the basal levels of motilin but did not alter the increment of motilin levels after domperidone administration, suggesting that dopaminergic mechanisms exert a tonic inhibitory effect on motilin secretion in normal subjects (Funakoshi et al. 1983 ). Using an enzymatic method, dispersed cells from the canine duodenojejunal mucosa were separated by centrifugal counterflow elutriation to enrich motilin content, and carbachol dose-dependently stimulated the release of motilin from its enriched cells (Poitras, et al. 1993) . Moreover, bombesin, morphine, and erythromycin stimulated motilin release in vivo, but did not influence the secretion of motilin in vitro (Poitras et al. 1993) . Serotonin, GIP, CCK, pentagastrin, cisapride, neosynephrine, isoproterenol, and muscimol also had no effect on motilin release in an in vitro model (Poitras et al. 1993) . The response to carbachol was abolished by atropine but was not affected by somatostatin, serotonin, secretin, CCK, or GIP (Poitras et al. 1993) . These results suggest that muscarinic receptors are present on the motilin cell membrane and that acetylcholine is a major regulator of motilin release. It is well known that the stomach is a major source of circulation plasma ghrelin, and the levels were elevated in a fasting state and returned to basal levels after re-feeding (Cummings, et al. 2001; Cummings, et al. 2002) . In contrast, peptide content of ghrelin in the stomach decreased after fasting, indicating that cytoplasmic ghrelin released from gastric ghrelin cells caused an increase in plasma ghrelin levels (Toshinai, et al. 2001) . The effects of nutrients on ghrelin release have been studied in detail. Oral and intravenous glucose administration sharply reduced plasma ghrelin concentration in rodents, and this effect of glucose on ghrelin inhibition was similar to that found in humans (Broglio, et al. 2004; Soriano-Guillen, et al. 2004 ). In addition to glucose, it has been reported that duodenal and jejunal infusions of lipids reduced ghrelin levels in rats and that infusion of amino acids also induced ghrelin suppression in rats (Overduin, et al. 2005) . Although further studies are needed to elucidate the molecular mechanisms of ghrelin secretion from the stomach by nutrients, nutrients may be directly involved in the rapid decline of plasma ghrelin concentration after feeding. Ghrelin secretion is regulated by peptide and steroid hormones. For example, ghrelin cells are located close to somatostatin-producing D cells, and somatostatin inhibits ghrelin secretion in rats and humans (Broglio, et al. 2002; Shimada, et al. 2003) . Ghrelin secretion from the perfused stomach was also stimulated by glucagon treatment in a dose-dependent manner (Kamegai, et al. 2004) , and this effect was shown to be mediated by glucagon receptors on ghrelin cells (Katayama, et al. 2007) . de la Cour et al. found that epinephrine, norepinephrine, endothelin and secretin stimulated ghrelin release (de la Cour, et al. 2007 ). In addition, steroid hormone is involved in ghrelin regulation. In humans, estrogen regulates plasma ghrelin concentration (Paulo, et al. 2008 ) (Kellokoski, et al. 2005 . In female rats, the levels of gastric ghrelin mRNA and plasma ghrelin and the number of ghrelin cells were found to be transiently increased by ovariectomy (Matsubara, et al. 2004) , and treatment of gastric mucosal cells with estrogen showed that estrogen stimulated ghrelin expression and ghrelin secretion ) (Zhao, et al. 2008) . Recently, ghrelinproducing cell lines have been generated by different two groups. Iwakura et al. generated ghrelin cell lines from the stomach and showed that insulin decreased ghrelin secretion into culture medium (Iwakura, et al. 2010 ). Zhao et al. also established different ghrelin cell lines from the stomach and pancreas, and they showed that adrenaline and noradrenaline stimulated ghrelin secretion and that ghrelin-secreting cells express high levels of mRNA encoding beta(1)-adrenergic receptors (Zhao, et al. 2010) . Moreover, they reported that fasting-induced increase in plasma ghrelin was blocked by treatment with reserpine to www.intechopen.com
The Gut Peptide Hormone Family, Motilin and Ghrelin 9 deplete adrenergic neurotransmitters from sympathetic neurons and that inhibition was also seen following administration of atenolol, a selective beta1-adrenergic antagonist, suggesting that sympathetic neurons are involved in ghrelin secretion by directly acting on beta1 receptors (Zhao et al. 2010 ).
Conclusion and future perspectives
Although ghrelin was discovered more than twenty years after motilin was identified, the biological and physiological functions of ghrelin have been studied in more detail than those of motilin. The major reason for this is due to the lack of a motilin gene in experimental rodents like mice and rats, which are used for biological and physiological analysis. So far, dogs and/or rabbits have been used for motilin studies, but these animals are too large to perform detailed analysis. Research has also been limited by the ban on use of genetically engineered mice. To resolve this problem and expand studies on motilin and its relationship with ghrelin, we established suncus as a novel motilin-and ghrelin-producing laboratory animal for motilin study. It has been shown that suncus motilin exerted phase III contraction in MMC using in vivo and in vitro experiments. This new suncus model will enable the detailed molecular and physiological analysis that were difficult using dogs and rabbits, and suncus will therefore be a powerful tool to understand the detailed mechanisms of motilinand/or ghrelin-induced gastrointestinal motility. 
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